RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
LEUKEMIA
Collezione AOU San Luigi di Orbassano

Items : 6

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy. in Leukemia / Leukemia. 2022 Jul;36(7):1879-1886. doi: 10.1038/s41375-022-01612-2. Epub 2022 Jun 8.

2022
AOU San Luigi di Orbassano

Salmon M; White HE; Zizkova H; Gottschalk A; Motlova E; Cerveira N; Colomer D; Coriu D; Franke GN; Gottardi E; Izzo B; Jurcek T; Lion T; Schäfer V; Venturi C; Vigneri P; Zawada M; Zuna J; Hovorkova L; Koblihova J; Klamova H; Markova MS; Srbova D; Benesova A; Polivkova V; Zackova D; Mayer J; Roeder I; Glauche I; et alii...

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. in Leukemia / Leukemia. 2022 Jul;36(7):1834-1842. doi: 10.1038/s41375-022-01607-z. Epub 2022 May 25.

2022
AOU San Luigi di Orbassano

White HE; Salmon M; Albano F; Andersen CSA; Balabanov S; Balatzenko G; Barbany G; Cayuela JM; Cerveira N; Cochaux P; Colomer D; Coriu D; Diamond J; Dietz C; Dulucq S; Engvall M; Franke GN; Gineikiene-Valentine E; Gniot M; Gómez-Casares MT; Gottardi E; Hayden C; Hayette S; Hedblom A; Ilea A; Izzo B; Jiménez-Velasco A; Jurcek T; Kairisto V; et alii...

Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey. in Leukemia / Leukemia. 2020 Aug;34(8):2260-2261. doi: 10.1038/s41375-020-0904-z. Epub 2020 Jun 18.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rosti G; Rege-Cambrin G; Pregno P; Luciano L; Latagliata R; Iurlo A; Gozzini A; Gugliotta G; Galimberti S; Fava C; Castagnetti F; Bonifacio M; Bocchia M; Abruzzese E; Breccia M; Stagno F; Tiribelli M; Foà R; Saglio G; Breccia M; Abruzzese E; Bocchia M; Bonifacio M; Castagnetti F; Fava C; Galimberti S; Gozzini A; Gugliotta G; Iurlo A; et alii...

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale. in Leukemia / Leukemia. 2016 Sep;30(9):1844-52. doi: 10.1038/leu.2016.90. Epub 2016 Apr 25.

2016
AOU San Luigi di Orbassano

Cross NC; White HE; Ernst T; Welden L; Dietz C; Saglio G; Mahon FX; Wong CC; Zheng D; Wong S; Wang SS; Akiki S; Albano F; Andrikovics H; Anwar J; Balatzenko G; Bendit I; Beveridge J; Boeckx N; Cerveira N; Cheng SM; Colomer D; Czurda S; Daraio F; Dulucq S; Eggen L; El Housni H; Gerrard G; Gniot M; et alii...

A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma. in Leukemia / Leukemia. 2016 Jun;30(6):1320-6. doi: 10.1038/leu.2016.36. Epub 2016 Feb 22.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Sonneveld P; Offidani M; Boccadoro M; Musolino C; De Paoli L; Conticello C; Nozzoli C; Aghemo E; Derudas D; Genuardi M; Guglielmelli T; Carella AM; Ponticelli E; Spada S; Vincelli ID; De Rosa L; Omedé P; Morabito F; Montefusco V; Passera R; Benevolo G; Liberati AM; Falcone AP; Caravita T; Villani O; Oliva S; Petrucci MT; Bringhen S; et alii...

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib. in Leukemia / Leukemia. 2015 Sep;29(9):1823-31. doi: 10.1038/leu.2015.152. Epub 2015 Jun 19.

2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pane F; Martinelli G; Cavo M; Alimena G; Testoni N; Soverini S; Venturi C; Leoni P; Cavazzini F; Rossi G; Gherlinzoni F; Pregno P; Levato L; Intermesoli T; Martino B; Albano F; Abruzzese E; Iurlo A; Stagno F; Breccia M; Gugliotta G; Castagnetti F; Saglio G; Rosti G; Baccarani M;